# Arrowhead Pharmaceuticals, Inc.: Form 8-K, filed Mar 20, 2026

- Company: [Arrowhead Pharmaceuticals, Inc.](/companies/arwr.md) (CIK 879407)
- Form: 8-K
- Filed: 2026-03-20
- Accepted by EDGAR: Mar 20, 2026, 16:05 ET
- Period: 2026-03-19
- Accession: 0000879407-26-000037
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/879407/000087940726000037/arwr-20260319.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/879407/000087940726000037/

## Items reported

- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/879407/000087940726000037/arwr-20260319.htm

Filed Mar 20, 2026.
Source: SEC EDGAR, the filing index for accession 0000879407-26-000037. Last ingested by Listed: Nov 5, 2026, 13:51 ET. No prices; not investment advice.